LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 9 of 15: Cell count and normalized growth rate inhibition values within biological replicate 2. - Dataset (ID:20246)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-231 | CGP60474 | 10 | uM | LJP6 | 1 | G01 | 72 | hr | 1311 | 688 | 4870 | 0.1413 | -0.2889 |
MDA-MB-231 | CGP60474 | 10 | uM | LJP6 | 2 | G01 | 72 | hr | 1311 | 658 | 4961 | 0.1326 | -0.3019 |
MDA-MB-231 | CGP60474 | 10 | uM | LJP6 | 3 | G01 | 72 | hr | 1311 | 529 | 4973 | 0.1064 | -0.3764 |
MDA-MB-231 | CGP60474 | 10 | uM | LJP5 | 1 | F01 | 72 | hr | 1311 | 793 | 5128 | 0.1546 | -0.2257 |
MDA-MB-231 | CGP60474 | 10 | uM | LJP5 | 2 | F01 | 72 | hr | 1311 | 809 | 5100 | 0.1586 | -0.2186 |
MDA-MB-231 | CGP60474 | 10 | uM | LJP5 | 3 | F01 | 72 | hr | 1311 | 812 | 5010 | 0.1621 | -0.2197 |
MDA-MB-231 | PD173074 | 0.04 | uM | LJP6 | 1 | I12 | 72 | hr | 1311 | 5054 | 4870 | 1.0377 | 1.0395 |
MDA-MB-231 | PD173074 | 0.04 | uM | LJP6 | 2 | I12 | 72 | hr | 1311 | 5238 | 4961 | 1.0557 | 1.0573 |
MDA-MB-231 | PD173074 | 0.04 | uM | LJP6 | 3 | I12 | 72 | hr | 1311 | 5094 | 4973 | 1.0242 | 1.0250 |
MDA-MB-231 | PD173074 | 0.12 | uM | LJP6 | 1 | I11 | 72 | hr | 1311 | 4828 | 4870 | 0.9913 | 0.9908 |
MDA-MB-231 | PD173074 | 0.12 | uM | LJP6 | 2 | I11 | 72 | hr | 1311 | 5397 | 4961 | 1.0877 | 1.0896 |
MDA-MB-231 | PD173074 | 0.12 | uM | LJP6 | 3 | I11 | 72 | hr | 1311 | 5084 | 4973 | 1.0222 | 1.0229 |
MDA-MB-231 | PD173074 | 0.37 | uM | LJP6 | 1 | I10 | 72 | hr | 1311 | 5072 | 4870 | 1.0414 | 1.0434 |
MDA-MB-231 | PD173074 | 0.37 | uM | LJP6 | 2 | I10 | 72 | hr | 1311 | 5312 | 4961 | 1.0706 | 1.0724 |
MDA-MB-231 | PD173074 | 0.37 | uM | LJP6 | 3 | I10 | 72 | hr | 1311 | 5194 | 4973 | 1.0443 | 1.0456 |
MDA-MB-231 | PD173074 | 1.11 | uM | LJP6 | 1 | I09 | 72 | hr | 1311 | 5195 | 4870 | 1.0667 | 1.0694 |
MDA-MB-231 | PD173074 | 1.11 | uM | LJP6 | 2 | I09 | 72 | hr | 1311 | 5061 | 4961 | 1.0200 | 1.0208 |
MDA-MB-231 | PD173074 | 1.11 | uM | LJP6 | 3 | I09 | 72 | hr | 1311 | 5314 | 4973 | 1.0684 | 1.0700 |
MDA-MB-231 | PD173074 | 3.33 | uM | LJP6 | 1 | I08 | 72 | hr | 1311 | 5089 | 4870 | 1.0449 | 1.0470 |
MDA-MB-231 | PD173074 | 3.33 | uM | LJP6 | 2 | I08 | 72 | hr | 1311 | 5064 | 4961 | 1.0206 | 1.0214 |
MDA-MB-231 | PD173074 | 3.33 | uM | LJP6 | 3 | I08 | 72 | hr | 1311 | 5305 | 4973 | 1.0666 | 1.0682 |
MDA-MB-231 | PD173074 | 10 | uM | LJP6 | 1 | I07 | 72 | hr | 1311 | 808 | 4870 | 0.1659 | -0.2259 |
MDA-MB-231 | PD173074 | 10 | uM | LJP6 | 2 | I07 | 72 | hr | 1311 | 670 | 4961 | 0.1350 | -0.2953 |
MDA-MB-231 | PD173074 | 10 | uM | LJP6 | 3 | I07 | 72 | hr | 1311 | 1061 | 4973 | 0.2133 | -0.1045 |
MDA-MB-231 | Crizotinib | 0.04 | uM | LJP5 | 1 | A24 | 72 | hr | 1311 | 4406 | 5128 | 0.8591 | 0.8514 |